Angeline K. Shashlo
Corporate Officer/Principal presso Metabolic Solutions Development Co. LLC
Profilo
Angeline K.
Shashlo is the founder of Tobira Therapeutics, Inc. She currently holds the position of Vice President-Development at Metabolic Solutions Development Co. LLC and Cirius Therapeutics, Inc. She previously held positions as VP-Regulatory Affairs & Quality Assurance at Incyte Corp., Senior Vice President at Genaera Corp., Principal at The Upjohn Co., Ligand Pharmaceuticals, Inc., VitaGen, Inc., and Wyeth-Ayerst Research, and Staff Pharmacist at Harper Grace Hospital.
She received her undergraduate degree from the University of Michigan.
Posizioni attive di Angeline K. Shashlo
Società | Posizione | Inizio |
---|---|---|
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Corporate Officer/Principal | 01/01/2009 |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Angeline K. Shashlo
Società | Posizione | Fine |
---|---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Corporate Officer/Principal | 13/07/2009 |
Harper Grace Hospital
Harper Grace Hospital Hospital/Nursing ManagementHealth Services Part of Blue Ridge HealthCare System, Inc., Harper Grace Hospital is an American company. | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
The Upjohn Co. | Corporate Officer/Principal | - |
LIGAND PHARMACEUTICALS INCORPORATED | Consigliere Generale | - |
Formazione di Angeline K. Shashlo
University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INCYTE CORPORATION | Health Technology |
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
Aziende private | 8 |
---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
The Upjohn Co. | Health Technology |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Health Technology |
VitaGen, Inc.
VitaGen, Inc. Medical SpecialtiesHealth Technology VitaGen, Inc. develops and manufactures extracorporeal liver assisting devices. The company was founded in 1990 and is headquartered in La Jolla, CA. | Health Technology |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Wyeth-Ayerst Research | |
Harper Grace Hospital
Harper Grace Hospital Hospital/Nursing ManagementHealth Services Part of Blue Ridge HealthCare System, Inc., Harper Grace Hospital is an American company. | Health Services |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Angeline K. Shashlo